Ola Vedin

Ola Vedin

Company: Boehringer Ingelheim

Job title: Global Medical Director Heart Failure

Seminars:

Moderated Discussion – Outlining Methods to Improve the Quality of Life for HFpEF Patients 3:15 pm

What has been observed in previous trials with respect to mortality rates and what have interim analyses shown? What steps have been taken to improve this definition for HFpEF patient? How does changing the definition for quality of life subsequently alter the drug development industry?Read more

day: Day Two

Symptoms, Physical Limitation & Quality of Life – Burden & Relevance in HFpEF 1:45 pm

Define and measure symptom burden, physical limitation and QoL in HFpEF To what extent is symptom burden and physical limitation in HFpEF driven by HF vs other comorbidities? Explore the impact of current treatment alternatives on symptoms and QoL in HFpEFRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.